• Delivering innovative research
    to the therapy analysis market
  • Identifying and commercializing
    first-in-class innovation in early stage development
  • Thought provoking insights
    covering hot topics and key industry issues
  • Providing specialty research and data
    to the devices and diagnostics industries

Research Services

GBI Research provides intelligence from high-growth therapy areas and novel drug treatments to pioneering companies and their strategies

Research Services
You are here:
Research Services

Research Services

GBI Research provides intelligence from high-growth therapy areas and novel drug treatments to pioneering companies and their strategies

Our research services provide essential intelligence for executives, investors and researchers all working within the life sciences sector. Both individuals and companies can benefit from the vast amount of research areas which GBI Research covers.

We offer multiple research areas within our solution, with quality reports offering significant benefits to executives, investors and researchers. They enable companies and individuals to react quickly to new regulations and policies, helping them to align their product portfolio with the current market demand and supporting the development of strong market-entry strategies.

Our Research Service Modules:

Therapy Analysis

Analysis of clinical trials, late stage pipeline activity and identification of trends in late stage and marketed products, as well as providing epidemiology, market sizing and forecast data

Frontier Pharma

Focused on innovative drug discovery and development to assess the validity and strength of specific molecular targets and mechanisms of action for first-in-class products. Insights into longer term clinical and ultimately commercial opportunities

CBR Pharma Insights

Strategic assessment of key R&D, corporate, legislative and commercial issues and events shaping the pharma industry in both established and emerging markets

Analyst Views

28 Nov 16
Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer’s ....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the potential f.....
Read post
21 Nov 16
Urological Cancer Treatment Landscape to be Transformed by ....
In this Analyst View, Adam Bradbury, Associate Analyst for GBI Research, discuses current.....
Read post

White Papers

22 Nov 16
An Exploration of Novel and Repositioned Calcium Transport ....
This whitepaper discusses the increasing interest in using repositioned calcium transport....
Read post
14 Nov 16
The Emerging Field of Cannabinoid-Based Products....
This white paper discusses the current commercial landscape for cannabinoid-based product....
Read post

Press Releases

17 Oct 17
Industry pipeline for monoclonal antibodies encompasses ove....
The overall industry pipeline for monoclonal antibodies (mAbs) has reached a unprecedente.....
Read post
13 Oct 17
New Diabetes Therapeutics to Steal Ground from Insulin Ther....
The incidence of diabetes mellitus (DM), and most notably type 2 diabetes mellitus (T2DM).....
Read post